Are Neogen Chemicals latest results good or bad?

Neogen Chemicals has reported its financial results for the quarter ending March 2025, showcasing a mix of operational trends. The company achieved net sales of Rs 202.82 crore, representing the highest figure in the last five quarters, which indicates a positive near-term sales trend. Additionally, the operating profit (PBDIT) reached Rs 36.38 crore, also the highest in the same timeframe, with an operating profit margin of 17.94%, suggesting improved efficiency in operations. However, the company faced challenges as well. Interest expenses for the nine-month period rose to Rs 38.68 crore, an increase of 28.80% compared to the previous nine months, highlighting a potential rise in borrowings. Profit after tax (PAT) for the quarter was reported at Rs 11.63 crore, reflecting a decline of 5.8% compared to the average PAT of Rs 12.34 crore over the preceding four quarters, indicating a negative near-term trend. Furthermore, earnings per share (EPS) fell to Rs 0.91, marking the lowest level in the last five quarters, which points to declining profitability for shareholders. In light of these results, Neogen Chemicals experienced an adjustment in its evaluation, reflecting the complexities of its financial performance during this period.